Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Retrovirology|May 17, 2007
Antigen-presenting particle technology using inactivated surface-engineered viruses: induction of immune responses against infectious agentsJoseph D Mosca, Yung-Nien Chang, Gregory WilliamsJournal of Cutaneous Medicine and Surgery|March 17, 2015
Recovery of Transplanted Eyebrow From Radiation-Induced Anagen EffluviumEkpemi Irune, Florian Bast, Gregory Williams, et al.Microbial Drug Resistance (Larchmont, N.Y.)|March 6, 2014
Activity of ceftaroline-avibactam tested against contemporary Enterobacteriaceae isolates carrying β-lactamases prevalent in the United StatesMariana Castanheira, Gregory Williams, Ronald N Jones, et al.International Journal of Antimicrobial Agents|October 4, 2014
Supporting the ceftaroline fosamil/avibactam Enterobacteriaceae breakpoint determination using humanised in vivo exposures in a thigh modelAmira A Bhalodi, Jared L Crandon, Gregory Williams, et al.Antimicrobial Agents and Chemotherapy|September 18, 2013
In vivo efficacy of humanized ceftaroline fosamil-avibactam exposures in a polymicrobial infection modelAmira A Bhalodi, Jared L Crandon, Gregory Williams, et al.IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control|August 5, 2003
Coded excitation with spectrum inversion (CEXSI) for ultrasound array imagingYao Wang, Kurt Metzger, Douglas N Stephens, et al.Antimicrobial Agents and Chemotherapy|April 27, 2011
In vivo efficacy of a human-simulated regimen of ceftaroline combined with NXL104 against extended-spectrum-beta-lactamase (ESBL)-producing and non-ESBL-producing EnterobacteriaceaeDora E Wiskirchen, Jared L Crandon, Guilherme H Furtado, et al.Antimicrobial Agents and Chemotherapy|February 15, 2012
Efficacy of human simulated exposures of ceftaroline against phenotypically diverse Enterobacteriaceae isolatesSeth T Housman, Rebecca A Keel, Jared L Crandon, et al.Aerosol Science and Technology : the Journal of the American Association for Aerosol Research|December 11, 2023
Comparison of the performance of aerosol sampling devices for measuring infectious SARS-CoV-2 aerosolsShanna Ratnesar-Shumate, Kyle Bohannon, Gregory Williams, et al.Psychiatry|October 20, 2004
Follow-up after inpatient psychiatric hospitalization with partial control of the system responsiveness variableRif S El-Mallakh, Tina James, Tehmina Khan, et al.Pageof 3